GeneHarbor
Pioneering In Vitro Enzyme Production Technology
For over 20 years, our company has built a world-leading, groundbreaking in vitro enzyme production system — powered by our original intellectual property.
Superior Purity
Achieves target product purity over 99.9%, greatly reducing downstream purification costs.
Cost-Effective
Mild reaction conditions lower energy and raw material consumption, driving down overall production costs.
Eco-Friendly
No high-pollution organic solvents needed. Lower energy use, less solid waste — true green manufacturing.
Highly Versatile
Modular, scalable, and broadly applicable — ideal for commercial production of most high-value-added biotech products.
Our Three Core Advantages
01
基因港是全球唯一一傢俱備完整酶制劑產業鏈，且在該產業鏈所有主要步驟均擁有世界領先技術的公司。
02
本公司的主要著眼點並不在於現有酶制劑之改良，而是更注重發見和開發具有新功能的新型酶制劑，從而開闢和拓展使用本公司技術的新市場。
03
過去二十餘年間，本公司使用新型酶法制備的諸產品深獲市場認可；目前已與抗生素、功能食品、化工及醫藥行業的數個龍頭企業建立實質性長期合作。
Our Three Core Advantages
1. GeneHarbor is one of the few companies in the world with a whole enzymatic industry chain — and world-leading technology at every major step of that chain.
2. Our primary focus lies not in refining existing enzyme preparations, but in discovering and developing new ones with novel functions — creating and expanding new markets for our technology.
3. Our novel enzymatic methods have produced numerous market-recognized products over the past two decades, alongside substantive partnerships with companies across the antibiotic, functional food, personal care, and pharmaceutical/healthcare sectors.
Why Choose GeneHarbor
Leading Technology
One of the Few Companies Worldwide with a Whole Enzymatic Industry Chain
Patented Technology Across the Full Industry Chain
In Vitro Enzyme Production Technology
Authoritative Certification
World's First FDA GRAS Notice
The Choice for Scientific Research
Harvard Clinical Research Supplier
Brand Heritage
Backed by Over 20 Years at Hong Kong Science Park
Why Choose GeneHarbor
Leading Technology
全球少數具備完整酵素製劑產業鏈
成本革命
售價僅同類1/20
Authoritative Certification
全球首家GRAS認證
科學研究驗證
哈佛原料商20+篇發表
Brand Heritage
20+香港科學園背書
Endorsed by Authoritative Bodies
Our Story
GeneHarbor was founded in Hong Kong in 2000, dedicated to the development of novel biocatalysts (enzymes), their industrial-scale manufacturing, and their commercial applications across various industrial sectors. In recent years, we have successfully reduced the cost of industrial production over a dozen products—including Glutathione, S‑Adenosylmethionine (SAMe), and NMN—using in vitro enzymatic processes in place of traditional fermentation.
GeneHarbor's in vitro enzyme production system is highly versatile and can be applied to the commercial manufacturing of most high-value-added biotechnology products.
Whole Enzymatic Production Chain
GeneHarbor is one of the few companies in the world with a whole enzymatic industry chain — and world-leading technology at every major step of that chain. Our primary focus lies not in refining existing enzyme preparations, but in discovering and developing new ones with novel functions — creating and expanding new markets for our technology. We have already commercialized or are commercializing more than ten viable scientific concepts into popular industrial products with significant market potential.
Whole Enzymatic Production Chain
01 顯微發現
裂變與細胞基因新功能的關鍵， 奠定創新基礎。
02 Genetic Engineering
透過基因工程與結構化調 性能，提升生產效率。
03 製體生產
先進製腺技術與工程控制，確保 高產率與高穩定度。
04 Industrial Application
廣泛應用於各個行業，為客戶 創造高附加值產品與效益。
基因港是全球其中一傢俱備完整酶制劑產業鏈，且在該產業鏈所有主要步驟均擁有世界領先技術的公司。本公司的主要著眼點並不在於現有酶制劑之改良，而是更注重發見和開發具有新功能的新型酶制劑，從而開闢和拓展使用本公司技術的新市場。本公司已經或正在將十餘項可行的科學概念商業化為市場潛力巨大、風行的工業產品。
Professor WANG Jun - THE FOUNDER
The goal of scientific research is not only longevity (lifespan),
but also healthy longevity (healthspan).
Academic Background
- First Group of Students Abroad After China's 1978 Reform and Opening-Up
- Earned his Ph.D. in Molecular Biology from the University of Wisconsin-Madison
Industrial Experience
- Over 40 years of experience in molecular biology, biotechnology R&D, and industrial-scale production at universities, government agencies, and biotech companies across China, the United States, Australia, and Hong Kong
- Founded GeneHarbor in 2000
- Inventor or co-inventor of 80+ patents.
Professional Appointments
- The First Industrial Research Chair funded by Innovation and Technology Commission of Hong Kong Government
- The Mentor at Hong Kong X-Tech Startup Platform
- A Review Committee Member of Innovation and Technology Fund by Hong Kong Government
Invention Patents
Chinese Invention Patent Certificate ZL 2021 1 0394288.5
Preparation methods of mononucleotide of nicotinic acid or derivative thereof and biological product of mononucleotide
Chinese Invention Patent Certificate ZL 2019 1 1146375.8
Hair care composition and preparation method therefor
Chinese Invention Patent Certificate ZL 2021 1 1550053.7
Oral care additive, oral care composition, preparation method, kit and application thereof